These sections summarize the data on ritonavir-boosted nirmatrelvir, remdesivir, and other antiviral medications.
These sections summarize the data on monoclonal antibodies, convalescent plasma, and SARS-CoV-2 immunoglobulins.
Review the data on the use of mesenchymal stem cells for the treatment of COVID-19.
These sections summarize the data on IL-6 inhibitors, kinase inhibitors, and other immunomodulators.
This section discusses screening, prevention, and treatment for thromboembolism in people with COVID-19.
Review the data on using certain concomitant therapies in people with COVID-19.
These sections discuss the rationale for using supplements in people with COVID-19.